Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN12767014
ISRCTN12767014Completed未知

Integrated cervical cancer screening in Mayuge district Uganda (ASPIRE Mayuge): a pragmatic cluster randomized control trial

niversity of British Columbia0 sites2,019 target enrollmentStarted: May 17, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
2,019
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32005202 protocol (added 03/02/2020) 2022 Preprint results in https://dx.doi.org/10.2139/ssrn.4068261 (added 30/06/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37037880/ (added 11/04/2023) 2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/36408923/ Participant experiences (added 06/06/2024)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • •1. Women with no previous history of hysterectomy or invasive cervical cancer
  • •2. Aged 25-49 years old
  • •3. Not previously been screened and treated for cervical cancer
  • •4. Provided written informed consent

Exclusion Criteria

  • •Do not fulfil inclusion criteria.

Investigators

Sponsor
niversity of British Columbia

Similar Trials

Completed
Not Applicable
Validation of a new dental scoring system to assess the junction in the mouth where the gums meet the teethHealthy dentate adult volunteers aged 18 or overOral Health
ISRCTN54471768niversity of Bristol39
Active, not recruiting
Phase 2
Radiotherapy combined with immunotherapy in metastatic non-small cell lung cancer patientsAdvanced non-small cell lung cancer, stage IVMalignant neoplasm the lung, non-small cell lung cancerCancer
ISRCTN49817477Maastricht University88
Completed
Not Applicable
Comparing different types of jet ventilation during endobronchial ultrasound guided transbronchial needle aspiratioEBUS-TBNA +/- tumour biopsyCancer
ISRCTN58911367Medical University of Vienna90
Terminated
Phase 2
apatinib plus capecitabine versus continued trastuzumab plus capecitabine after local therapy in patients with ErbB2-positive metastatic breast cancer developing brain metastasis/esBreast cancer, developing brain metastasis/esCancerBreast cancer
ISRCTN58771616eeds Teaching Hospitals NHS Trust (UK)30
Completed
Not Applicable
Comparing mental well-being of people with hearing loss who have been partnered with a hearing dog to those that have applied for, but not yet received a hearing dogEar, Nose and ThroatHearing loss
ISRCTN36452009niversity of York213